FDA Clearance Tracker · P860026
DIAPHRAGMATIC PACEMAKER PHRENIC NERVE STIMULATOR
Last checked: Nov 21, 2026Latest source record: Jan 5, 1987 (this decision)Source: openFDAMethods & limitations
Decided
Jan 5, 1987
Approved
Time to decision
186 days
Received Jul 3, 1986. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P860026
- Device name
- DIAPHRAGMATIC PACEMAKER PHRENIC NERVE STIMULATOR
- Applicant
- Avery Biomedical Devices, Inc.
- Applicant location
- Commack, NY
- Received
- Jul 3, 1986
- Decided
- Jan 5, 1987
- Decision
- Approved
- Supplements
- 9 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Regulation
- 21 CFR 882.5830
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code GZE (implanted diaphragmatic/phrenic nerve Stimulator).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Avery Biomedical Devices, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.